Invited Review

Spinal Surgical Site Infections: A Pre- and Post-COVID-19 Comparison of Perioperative Factors and Surgical Outcomes

Paul McMillan MBChB, MSc

Department of Orthopaedic Surgery University of Cincinnati Cincinnati, OH

Logan P. Lake, BS

Department of Orthopaedic Surgery University of Cincinnati Cincinnati, OH

Isaac C. Hale, BS

Department of Orthopaedic Surgery University of Cincinnati Cincinnati, OH

Zachary Crawford, MD, PharmD

Department of Orthopaedic Surgery OrthoAtlanta Atlanta, GA

Scott Emmert, MD

Department of Orthopaedic Surgery University of Cincinnati Cincinnati, OH

Benjamin E. Jevnikar, BA

Department of Orthopaedic Surgery University of Cincinnati Cincinnati, OH

John Bonamer, MD

Department of Orthopaedic Surgery University of Pittsburgh Medical Center Pittsburgh, PA

Shawn A. Moore, BS

Department of Orthopaedic Surgery University of Cincinnati Cincinnati, OH

Erin Grawe, MD

Department of Anesthesiology University of Cincinnati Cincinnati, OH

Anthony Guanciale, MD

Department of Orthopaedic Surgery University of Cincinnati Cincinnati, OH


Introduction

Surgical site infections (SSI) are a significant cause of morbidity and mortality in the hospital setting, with reported incidence rates of 2-5%.1 Defined as perioperative infections arising from the superficial incisional, deep incisional, or organ spaces of a surgical site, SSIs are among the costliest of all hospital acquired infections (HAI).3 They impose a substantial financial burden to the United States health care sector of approximately $3.5 to $10 billion USD annually.1 Costs are primarily driven by direct expenses associated with prolonged inpatient stays, readmission, antibiotic therapies, diagnostic tests, imaging studies, and secondary procedures. There are also indirect expenses related to long-term functional impairment for the patient.2

The COVID-19 pandemic presented numerous challenges to the health care sector, although one benefit was the heightened scrutiny of and emphasis on hospital hygiene, infection control, and antimicrobial/antiviral risk mitigation strategies. Studies in the literature suggest that the stringent implementation of these measures during the COVID-19 pandemic had varying impacts on reducing incidence of SSIs at surgical centers worldwide.2,6,13,14 However, there remains a gap in our understanding of the perioperative clinical and surgical characteristics and subsequent outcomes of patients undergoing spine surgery before versus after the onset of the COVID-19 pandemic, particularly concerning the development of spinal SSIs.

This study aims to address this deficiency by comparing  perioperative clinical and surgical characteristics and outcomes of patients who developed an SSI following spine surgery, before and after the onset of the COVID-19 pandemic.

Methods

A retrospective review was conducted of all patients who underwent elective, urgent, or emergent spinal procedures—including decompression (laminectomy) and instrumented fusion—of the cervical, thoracic, and lumbar spine at a single Level I trauma center between January 1, 2017, and January 1, 2023, who subsequently represented to our institution with a spinal surgical site infection. The onset of the COVID-19 pandemic was defined by the Center for Disease Control Museum COVID-19 guideline as January 20, 2020, which is the date of the first laboratory-confirmed case of COVID-19 in the United States. Pre-COVID was therefore defined as surgeries occurring before January 20, 2020, and post-COVID was defined as surgeries occurring on or after January 20, 2020. Patients with less than 2 weeks of follow-up at our institution were excluded from the study.

Patient demographics analyzed included age, gender, body mass index (BMI), smoking status, presence of diabetes mellitus, HbA1c within 60 days prior to operation, American Society of Anesthesiologist (ASA) physical status, pharmacologic and physiologic immunosuppression (cancer, human immunodeficiency virus/acquired immunodeficiency syndrome, history of transplant medication, steroids, anti-rheumatic disease-modifying antirheumatic drugs), confirmed prior COVID-19 infection, hospital location, surgeon specialty, and inpatient or outpatient status. Preoperative characteristics examined included an SSI-prevention bundle. This targeted Staphylococcus sp decolonization including screening for Staphylococcus aureus carrier status, treatment with intranasal mupirocin if identified as a carrier, administration of preoperative antibiotics, time between administration of antibiotics and surgery start time, preoperative nasal iodine application status, and pre-operative chlorhexidine gluconate bathing status. Operative characteristics analyzed included case class, type/approach of surgery, duration of surgery, and number of spinal levels involved. Postoperative clinical variables analyzed included length of inpatient stay, time from surgery to SSI readmission, and complications.

Statistical analysis was performed using IBM SPSS software package version 29.0 (Armonk, NY: IBM Corp). Continuous variables were evaluated using unpaired two-tailed t-tests or Mann-Whitney tests as appropriate. Categorical variables were compared using the Chi-square test or Fisher’s exact test. Normally distributed data is presented as mean + SD. Non-normally distributed data is presented as median (interquartile range [IQR]). A p value of < 0.05 was taken to indicate statistical significance.

Results

We identified 105 patients (57 pre-COVID onset, 48 post-COVID onset) who underwent emergent, urgent, or elective spine surgery and re-presented with an SSI during the study period. Of these patients, 56 (53%) were male and 49 (47%) were female. The mean age was 58.9 ± 13.6 years in the pre-COVID onset cohort and 63.0 ± 11.4 years in the post-COVID onset cohort. The mean BMI was 31.2 + 7.5 in the pre-COVID onset cohort and 33.3 + 6.2 in the post-COVID onset cohort. Table 1 outlines the patient demographics.

Post-COVID onset SSI patients had higher ASA scores (3.0 + 0.5 vs. 2.8 + 0.6, p = 0.017), higher prevalence of pharmacologic or physiologic immunosuppression (37.5% vs 12.3%, p = 0.003) and higher prevalence of COVID-19 infection (18.8% vs 0.0%, p < 0.001). These patient demographics are summarized in Table 1. Post-COVID patients were also more likely to undergo preoperative optimization with nasal iodine application and chlorhexidine gluconate (CHG) bathing, as well as more likely to undergo a posterior or combined approach rather than anterior approach (p = 0.039). The number of spinal levels either decompressed or fused was insignificant between pre-COVID (5.56 + 3.51) and post-COVID (6.23 + 3.40) cohorts (p = 0.327). Similarly, the frequency of surgical procedure performed (fusion vs decompression) did not significantly differ between pre- and post-COVID cohorts (OR: 0.356, p = 0.217). The surgical region (cervical, cervicothoracic, thoracic, thoracolumbar, lumbar-lumbosacral, and cervicothoracolumbar) was also not significantly different between cohorts (p = 0.385). Table 2 outlines the preoperative, operative and postoperative characteristics.

Post-COVID onset SSI patients were readmitted for infection later after surgery compared to pre-COVID onset SSI patients (34.2 + 20.4 vs. 26.8 + 13.1 days, p = 0.039 ) and experienced more postoperative complications, including postoperative anemia necessitating transfusion (p = 0.001), post-operative hypotension necessitating vasopressors (p = 0.001), acute kidney injury (p = 0.022), hardware damage (p = 0.019), hardware infection (p < 0.001) and spinal hematoma (p = 0.003). Table 3 outlines the complication incidence between pre-COVID onset versus post-COVID onset spinal SSI patients.

Perioperative COVID-19 diagnosis was positively correlated with higher ASA score (p = 0.030, r2 0.10) but did not influence the development of postoperative complications.

Table 1. Patient demographics prepandemic onset vs postpandemic onset. P value < 0.05 indicates statistical significance *. Odds ratio (95% confidence interval).

Table 2. Preoperative, operative and postoperative characteristics. P value < 0.05 indicates statistical significance *. Odds ratio (95% confidence interval). Immunosuppressed (cancer, human immunodeficiency virus/acquired immunodeficiency syndrome, history of transplant medication, steroids, antirheumatic disease-modifying antirheumatic drugs).

Table 3. Complication incidence prepandemic onset vs postpandemic onset. % (yes (n)/no (n)). P value < 0.05 indicates statistical significance. * Odds ratio (95% confidence interval).

Discussion

Although the post-COVID cohort contained predominantly sicker patients who underwent more rigorous perioperative optimization and experienced more postoperative complications, it is important to note that the higher incidence of postoperative complications observed in the post-COVID SSI cohort, when compared to the pre-COVID SSI cohort, was not correlated with the presence of COVID-19 infection.

Querying the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database, Momtaz et al conducted a retrospective analysis of 146,430 elderly patients who underwent elective orthopaedic procedures before (n = 94,289) and during (n = 52,141) the pandemic, respectively. Compared to the pre-COVID onset period, patients treated during the pandemic had 1.45 times increased likelihood of any complication, with varying relative risk of physiological system complications, including pulmonary (OR 1.76; 95% CI: 1.55-2.46), cardiac (OR 1.51; 95% CI 1.29 -1.78) and renal systems (OR 1.95; 95% CI 1.55 to 2.46).15 Similarly, Zhong et al, in their review of 40,986 patients from the Premier Healthcare database, reported increased odds of complications, inpatient readmission, intensive care unit admission, and higher treatment costs in patients undergoing orthopedic surgery during the pandemic compared to before.24 It is difficult to draw absolute conclusions regarding the cause of these complications. However, we observed that our post-COVID onset SSI cohort were more likely to have experienced postoperative complications such as anemia requiring transfusion, hypotension requiring vasopressors, and AKI, alongside higher ASA scores and immunosuppression not related to COVID-19 infection when compared to the pre-COVID SSI cohort. As such, there is a suggestion that the association between postoperative complications, higher ASA status and presence of pharmacologic and/or physiological immunosuppression with the development of an SSI post-COVID could be related to the diminished physiological reserve and deconditioning of many of our surgical patients.

These associations may represent important confounding factors, as both higher ASA status and immunosuppression are independently associated with increased risk of postoperative infection. The higher rates in the post-COVID group could be partly explained by changes in referral patterns and surgical triage during the pandemic, in which more complex and higher-risk patients were prioritized for surgery, while lower-risk elective cases were deferred. This shift in case mix may have contributed to the observed increase in SSI incidence in the post-COVID cohort, in addition to other postoperative complications noted. We hypothesize that this may also be a factor for the observed increase in post-operative hardware damage, hardware infection, and spinal hematoma in our post-COVID onset cohort compared to their pre-COVID onset counterparts.

Additionally, the relationship between preoperative medical optimization, perioperative health status, and postoperative complications is complex and undoubtedly multifaceted. Greater adherence to preoperative Staphylococcus sp decolonization interventions such as nasal iodine and CHG bathing, was noted in the post-COVID onset cohort in accordance with routine standard of care policies2, and pandemic-implemented policies to further optimize patient safety.

Several studies have highlighted the impact of delayed medical care on health outcomes during the pandemic.10, 17, 23 In the early phase of the pandemic, emergency department (ED) visits in the United States decreased by 42% compared to the previous year.11 Subsequent research has indicated that delayed ED presentations during the pandemic for concerns such as acute appendicitis and cholecystitis were associated with higher rates of complications.5, 8, 9, 18, 19 Public health research has also highlighted that fear of contracting COVID-19 was amongst the most common reasons for patients delaying healthcare treatment, ultimately increasing overall morbidity and mortality.4, 20 Our findings possibly support these observations: patients with spinal SSI may have delayed seeking medical care after the onset of the pandemic compared to before, resulting in delays in receiving timely treatment.

Another important consideration is the impact of the pandemic on physical activity levels. Preoperative physical activity levels have been shown to predict postoperative outcomes and the risk of postoperative complications.12 This forms the basis for prehabilitation methods, defined as a set of interventions undertaken prior to surgery to enhance cardiorespiratory fitness, reduce perioperative risk and enhance recovery and outcomes.7 During the COVID-19 pandemic, national isolation protocols, quarantine restrictions, lockdowns, business closures, and reduced social opportunities across the world significantly impacted physical activity levels. In a 2021 review of 66 studies involving 86,981 participants worldwide, Stockwell et al reported a significant decrease in physical activity and an increase in sedentary behavior since the onset of the pandemic.21 Oliveira et al observed similar findings among the elderly population in a systematic review of 25 studies16, while Momtaz et al suggest that these findings, and their probable impact on exacerbation of chronic diseases, may directly contribute to a higher incidence of postoperative complications during the pandemic.15

Our study has several limitations that should be considered. Firstly, our data was collected from the records of a single, level 1 trauma center, one of only two such institutions within a 75-mile radius of the largest metropolitan area in Ohio. This introduces an inherent selection bias towards patients of greater complexity, in an area with high socioeconomic deprivation, potentially limiting the generalizability of our findings to broader populations. Secondly, patient data was collected retrospectively based upon review of existing chart-coded diagnoses. Baseline risks of documentation errors, incomplete information, and coding inaccuracies are excepted limitations of this technique. Additionally, the case mix of patients differed between the pre- and post-COVID cohorts. During the pandemic, surgical triage policies and referral patterns may have led to prioritization of more complex or higher-risk patients for surgery, while lower-risk elective cases were deferred. This shift in case mix could have contributed to the observed increase in postoperative complications and SSI incidence in the post-COVID cohort, potentially confounding direct comparisons between the groups. Lastly, our study did not directly analyze the effects of specific infection control policies implemented during the pandemic on the incidence of SSI. Further investigation into this relationship could provide valuable insight into these policies' effectiveness in preventing SSI and enhancing patient outcomes.

Conclusion

In patients with spinal SSI, those operated on after the onset of the COVID-19 pandemic were more likely to be immunosuppressed and at higher perioperative risk. Greater adherence to preoperative Staphylococcus sp decolonization was observed in the post-COVID onset cohort in accordance with routine standard of care and pandemic-implemented policies to optimize patient safety. Our data suggests that readmission of SSI patients was delayed in the post-COVID onset era, perhaps due to pandemic-implemented isolation policies and subsequent patient hesitancy in seeking SSI treatment.

Importantly, the higher incidence of postoperative complications in patients developing spine related SSI in the post-COVID onset cohort was not correlated with COVID-19 infection, but may have been caused by factors such as patient deconditioning and delayed patient-physician interaction due to societal and health care challenges presented during the pandemic. Future research should focus on optimizing infection prevention protocols tailored to high-risk patient populations, further investigation of the impact of COVID-19 on surgical outcomes, and exploring strategies to mitigate postoperative complications.

Clinical Relevance

Our findings suggest that the higher incidence of surgical site infection (SSI) and postoperative complications observed in spine surgery patients after the onset of the COVID-19 pandemic was not directly attributable to the COVID-19 infection itself. Instead, these outcomes appear to be influenced by confounding factors, including higher ASA grade, greater prevalence of immunosuppression, delayed healthcare-seeking behavior, and pandemic-driven changes in referral and surgical triage that shifted case mix toward higher morbidity, higher-risk patients. Reduced physical activity and patient deconditioning during the pandemic may have further diminished physiological reserve, compounding complication risk.

Clinically, this underscores how systemic disruptions in health care, such as delays in treatment, surgical selection, and poor baseline patient health can indirectly worsen surgical outcomes. Health care systems and surgeons should account for these factors by prioritizing perioperative optimization – including prehabilitation, nasal iodine, and CHG bathing - and timely and equitable access to health care to maximize long-term surgical success.

References

  1. Anderson DJ, Podgorny K, Berríos-Torres SI, Bratzler DW, Dellinger EP, Greene L, et al. Strategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014 Jun 1;35(6):605–27.
  2. Atumanyire J, Muhumuza J, Talemwa N, Molen SF, Kithinji SM, Kagenderezo BP, Hakizimana T. Incidence and outcomes of surgical site infection following emergency laparotomy during the COVID-19 pandemic in a low resource setting: A retrospective cohort. Int J Surg Open. 2023. 56:100641. doi: 10.1016/j.ijso.2023.100641. Epub 2023 Jun 13.
  3. Ban KA, Minei JP, Laronga C, Harbrecht BG, Jensen EH, Fry DE, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2017 Jan;224(1):59–74.
  4. Beydoun HA, Beydoun MA, Alemu BT, Weiss J, Hossain S, Gautam RS, Zonderman AB. Determinants of COVID-19 Outcome as Predictors of Delayed Healthcare Services among Adults ≥50 Years during the Pandemic: 2006-2020 Health and Retirement Study. Int J Environ Res Public Health. 2022 Sep 23;19(19):12059. doi: 10.3390/ijerph191912059.
  5. Bonilla L, Gálvez C, Medrano L, Benito J. Impacto de la COVID-19 en la forma de presentación y evolución de la apendicitis aguda en pediatría. Anales de Pediatría. 2021 Apr;94(4):245–51.
  6. Chacón-Quesada T, Rohde V, Von Der Brelie C. Less surgical site infections in neurosurgery during COVID-19 times - one potential benefit of the pandemic? Neurosurg Rev. 2021 Dec;44(6):3421–5.
  7. Chmelo J, Chmelová I, Phillips AW. Prehabilitation, improving postoperative outcomes. Rozhl Chir. 2021 Fall;100(9):421–8. doi: 10.33699/PIS.2021.100.9.421-428.
  8. El Nakeeb A, Emile SH, AbdelMawla A, Attia M, Alzahrani M, ElGamdi A, et al. Presentation and outcomes of acute appendicitis during COVID-19 pandemic: lessons learned from the Middle East—a multicentre prospective cohort study. Int J Colorectal Dis. 2022 Apr;37(4):777–89.
  9. Fouad MMB, Rezk SSS, Saber AT, Khalifa A, Ibraheim P, Ibraheim SMN. Effect of the COVID-19 Pandemic on the Management of Acute Cholecystitis and Assessment of the Crisis Approach: A Multicenter Experience in EGYPT. Asian J Endoscop Surg. 2022 Jan;15(1):128–36.
  10. Gertz AH, Pollack CC, Schultheiss MD, Brownstein JS. Delayed medical care and underlying health in the United States during the COVID-19 pandemic: A cross-sectional study. Prev Med Rep. 2022 Aug;28:101882.
  11. Hartnett KP, Kite-Powell A, DeVies J, Coletta MA, Boehmer TK, Adjemian J, et al. Impact of the COVID-19 Pandemic on Emergency Department Visits — United States, January 1, 2019–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):699–704.
  12. Lawrence DC, Montazeripouragha A, Wai EK, Roffey DM, Phan KM, Phan P, et al. Beneficial Effects of Preoperative Exercise on the Outcomes of Lumbar Fusion Spinal Surgery. Physiother Can. 2023 Feb 8;75(1):22–28. doi: 10.3138/ptc-2021-0030.
  13. McLoughlin LC, Perlis N, Lajkosz K, Boasie A, Esmail T, Nielson C, et al. Surgical Site Infections During the Pandemic: The Impact of the COVID Bundle. World J Surg. 2023 Oct;47(10):2310–8. doi: 10.1007/s00268-023-07112-3. Epub 2023 Jul 24.
  14. Mimura T, Matsumoto G, Natori T, Ikegami S, Uehara M, Oba H, et al. Impact of the COVID-19 pandemic on the incidence of surgical site infection after orthopaedic surgery: an interrupted time series analysis of the nationwide surveillance database in Japan. J Hosp Infect. 2024. 146:160-165. doi: 10.1016/j.jhin.2023.06.001. Epub 2023 Jun 9.
  15. Momtaz D, Ghali A, Gonuguntla R, Kotzur T, Ahmad F, Arce A, et al. Impact of COVID-19 on Elective Orthopaedic Surgery Outcomes During the Peak of the Pandemic, an Uptick of Complications: An Analysis of the ACS-NSQIP. JAAOS Glob Res Rev. 2023 Feb [cited 2024 Jun 11];7(2). Available from: https://journals.lww.com/10.5435/JAAOSGlobal-D-22-00276.
  16. Oliveira MR, Sudati IP, Konzen VDM, De Campos AC, Wibelinger LM, Correa C, et al. Covid-19 and the impact on the physical activity level of elderly people: A systematic review. Exp Gerontol. 2022 Mar;159:111675.
  17. Ponce SA, Wilkerson M, Le R, Nápoles AM, Strassle PD. Inability to get needed health care during the COVID-19 pandemic among a nationally representative, diverse population of U.S. adults with and without chronic conditions. BMC Public Health. 2023 Sep 26;23(1):1868.
  18. Quaglietta PR, Ramjist JK, Antwi J, Kissoondoyal A, Lapidus-Krol E, Baertschiger RM. Unanticipated consequences of COVID-19 pandemic policies on pediatric acute appendicitis surgery. J Pediatr Surg. 2023 May;58(5):931–8.
  19. Rudnicki Y, Soback H, Mekiten O, Lifshiz G, Avital S. The impact of COVID-19 pandemic lockdown on the incidence and outcome of complicated appendicitis. Surg Endosc. 2022 May;36(5):3460–6.
  20. Soares P, Leite A, Esteves S, Gama A, Laires PA, Moniz M, et al. Factors Associated with the Patient's Decision to Avoid Healthcare during the COVID-19 Pandemic. Int J Environ Res Public Health. 2021 Dec 15;18(24):13239. doi: 10.3390/ijerph182413239.
  21. Stockwell S, Trott M, Tully M, Shin J, Barnett Y, Butler L, et al. Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review. BMJ Open Sport Exerc Med. 2021 Jan;7(1):e000960.
  22. Urban JA. Cost Analysis of Surgical Site Infections. Surg Infect. 2006 Jan;7(s1):s19–22.
  23. Zhong S, Huisingh‐Scheetz M, Huang ES. Delayed medical care and its perceived health impact among US older adults during the COVID‐19 pandemic. J Am Geriatr Soc. 2022 Jun;70(6):1620–8.
  24. Zhong H, Poeran J, Liu J, Sites BD, Wilson LA, Memtsoudis SG. Elective orthopedic surgery during COVID-19. Reg Anesth Pain Med. 2021 Sep;46(9):825–7.

Author Disclosures

P McMillan: Nothing to disclose

LP Lake: Nothing to disclose

IC Hale: Nothing to disclose

Z Crawford: Nothing to disclose

AS Emmert: Nothing to disclose

BE Jevnikar: Nothing to disclose

J Bonamer: Nothing to disclose

SA Moore: Nothing to disclose

E Grawe: Nothing to disclose

A Guanciale: Nothing to disclose

Bremer (Ad)

Previous Page

Literature Review

Next Page